We're very pleased to receive this esteemed award from Life Sciences Review in their annual listing of 10 companies that are at the forefront of providing Synthetic Biology solutions and transforming businesses.
In an interview, Daren Bryce and Valeria Valkova explained our latest developments and capabilities to provide enzyme development to Life Sciences and Pharma.
Biocatalysts’ aim is to bring unique solutions to clients that help them quickly scale up their projects. Our company utilises microbial fermentation technologies to enable the economical production of enzymes at a commercial scale. It has successfully run more than 50 fermentation scale-up projects across multiple strain platforms, including bacteria and yeast, and developed a wide range of enzyme classes. Biocatalysts starts working with clients at an early stage, understands their processes, conducts a custom scale-up, and drives them to the production stage.